Founded
Address
ARCH Venture Partners
1700 Owens Street
Suite 535
San Francisco, CA 94158
United States
Phone
Website
Recent investment activity
KANDO id: 30599
Corporate information
Official name
ARCH Venture Partners LP
Registration country
Company type
Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startupFunding rounds
Investment activity status
Active investor
Selected investments
Displaying 76 - 100 of 136| Company | Profile | Country | Date Sort descending | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Xcyte Therapies Inc | N/A | ||||
|
|
VLST Corp | N/A | ||||
|
|
VentiRx Pharmaceuticals Inc | N/A | ||||
|
|
Variation Biotechnologies (US) Inc | A vaccine development company dedicated to the innovative formulation | N/A | |||
|
|
Trubion Pharmaceuticals Inc | N/A | ||||
|
|
Groove Biopharma Corp | N/A | ||||
|
|
Sorbent Therapeutics Inc | N/A | ||||
|
|
Mirina Corp | N/A | ||||
|
|
Sapphire Energy Inc | N/A | ||||
|
|
Receptos Inc [] | N/A | ||||
|
|
Omeros Corp | Biopharmaceutical company committed to discovering, developing and commercializing products. | N/A | |||
|
|
NeurogesX Inc | N/A | ||||
|
|
Nura Inc | N/A | ||||
|
|
ePolicy Solutions Inc | Web-based technology services to the insurance industry. | N/A | |||
|
|
Permeon Biologics Inc | N/A | ||||
|
|
PhaseRx Inc | Develops novel approaches to the delivery of siRNA and other macromolecules | N/A | |||
|
|
PixelEXX Systems | N/A | ||||
|
|
Pulmatrix Inc | Discovering a new class of host-targeted therapies that pathogen independently treat | N/A | |||
|
|
Array BioPharma Inc | N/A | ||||
|
Cambrios Technologies Corp (Cambrios Advanced Materials) | Developer of proprietary nanostructured electronic materials for the display industry | Series B | |||
|
Nanosys Inc | Nanotechnology-enabled systems | Series D Initial investment | |||
|
|
Impinj Inc | N/A | ||||
|
|
KYTHERA Biopharmaceuticals Inc | Series B | ||||
|
|
Chiasma Corp | Series C | ||||
|
|
Impinj Inc | Series E |